Veterinary Vaccine Adjuvants Market By Type (Alum and Calcium Salts, Oil Emulsion Adjuvants, Liposomes and Archaeosomes, Nanoparticles and Microparticles, Others) , By Route of Administration (Oral, Subcutaneous, Intramuscular, Others) By Type of Animal (Livestock Animals, Companion Animals) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Veterinary Vaccine Adjuvants Market
The veterinary vaccine adjuvants market was valued at $0.4 billion in 2023 and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
A veterinary vaccine adjuvant is an element essential to enhance the immune response of the administered vaccine in animals. An adjuvant is a bioactive compound that upon addition elevates the immune response generated by vaccines. The mechanism of action of adjuvants involves enhancement in the antigen presentation process or modulation of immune pathways through the stimulation of certain receptors. The most common forms of adjuvants included in veterinary vaccines are oil emulsions, aluminum salts, liposomes, bacterial derivatives, and saponins.
Increase in the trend of petkeeping and surge in expenditure on their health are the key drivers of the veterinary vaccine adjuvants market. Moreover, the prevalence of diseases in animals has upsurged over the past few years, thereby boosting the demand for veterinary vaccine adjuvants. In recent times, the addition of nanoparticle-based adjuvants in vaccines is trending in the market as they offer controlled release and encapsulate the antigens, thus preventing their degradation. Furthermore, microparticle-based and genetic adjuvants are acquiring prominent traction owing to their highly targeted action mechanism.
However, several adjuvants potentially cause severe systemic reactions and local reactogenicity in animals, raising concerns pertaining to their safety and hampering the development of the market. In addition, advancements in vaccine development are eliminating the requirement of adjuvants, without limiting the efficacy of vaccines. Such innovations are anticipated to restrain the development of the market in upcoming years. Despite the innovations in vaccine formation, several gaps exist in the generation of effective immune response, such as pathogen variability and virulent reversion of vaccine strains. These shortcomings present lucrative opportunities for the players in the veterinary vaccine adjuvant market. Further, the implementation of different veterinary vaccination drives by governments, such as the foot and mouth disease vaccination program by the Department of Animal Husbandry & Dairying in India, open new avenues for market expansion.
Segment Review
The veterinary vaccine adjuvants market is segmented into type, route of administration, type of animal, and region. On the basis of type, the market is divided into alum & calcium salts, oil emulsion adjuvants, liposomes & archaeosomes, nanoparticles & microparticles, and others. By route of administration, it is classified into oral, subcutaneous, intramuscular, and others. As per type of animal, it is bifurcated into livestock animals and companion animals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the alum & calcium salts segment dominated the market in 2023.
By route of administration, the intramuscular segment accounted for a high market share in 2023.
As per type of animal, the livestock animals segment was the highest shareholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The leading players operating in the global veterinary vaccine adjuvants market include SEPPIC, SPI Pharma, Inc., Bioveta AS, Croda Internation PLC, Merck & Co., Inc., MVP Laboratories, OZ Biosciences, InvivoGen Corporation., Evonik Industries AG, and Zoetis, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Type
Alum and Calcium Salts
Oil Emulsion Adjuvants
Liposomes and Archaeosomes
Nanoparticles and Microparticles
Others
By Route Of Administration
Oral
Subcutaneous
Intramuscular
Others
By Type Of Animal
Livestock Animals
Companion Animals
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
SEPPIC
SPI Pharma, Inc.
Bioveta AS
Croda Internation PLC
Merck & Co., Inc.
MVP Laboratories
OZ Biosciences
InvivoGen Corporation.
Evonik Industries AG
Zoetis, Inc.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Alum And Calcium Salts
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Oil Emulsion Adjuvants
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Liposomes And Archaeosomes
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Nanoparticles And Microparticles
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Others
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
- CHAPTER 5: VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Route Of Administration
- 5.2. Oral
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Subcutaneous
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Intramuscular
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Type Of Animal
- 6.2. Livestock Animals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Companion Animals
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- CHAPTER 7: VETERINARY VACCINE ADJUVANTS MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Route Of Administration
- 7.2.4. Market Size and Forecast, By Type Of Animal
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Veterinary Vaccine Adjuvants Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Route Of Administration
- 7.2.6.3. Market Size and Forecast, By Type Of Animal
- 7.2.7. Canada Veterinary Vaccine Adjuvants Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Route Of Administration
- 7.2.7.3. Market Size and Forecast, By Type Of Animal
- 7.2.8. Mexico Veterinary Vaccine Adjuvants Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Route Of Administration
- 7.2.8.3. Market Size and Forecast, By Type Of Animal
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Route Of Administration
- 7.3.4. Market Size and Forecast, By Type Of Animal
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Veterinary Vaccine Adjuvants Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Route Of Administration
- 7.3.6.3. Market Size and Forecast, By Type Of Animal
- 7.3.7. France Veterinary Vaccine Adjuvants Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Route Of Administration
- 7.3.7.3. Market Size and Forecast, By Type Of Animal
- 7.3.8. UK Veterinary Vaccine Adjuvants Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Route Of Administration
- 7.3.8.3. Market Size and Forecast, By Type Of Animal
- 7.3.9. Italy Veterinary Vaccine Adjuvants Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Route Of Administration
- 7.3.9.3. Market Size and Forecast, By Type Of Animal
- 7.3.10. Spain Veterinary Vaccine Adjuvants Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Route Of Administration
- 7.3.10.3. Market Size and Forecast, By Type Of Animal
- 7.3.11. Rest Of Europe Veterinary Vaccine Adjuvants Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Route Of Administration
- 7.3.11.3. Market Size and Forecast, By Type Of Animal
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Route Of Administration
- 7.4.4. Market Size and Forecast, By Type Of Animal
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Veterinary Vaccine Adjuvants Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Route Of Administration
- 7.4.6.3. Market Size and Forecast, By Type Of Animal
- 7.4.7. China Veterinary Vaccine Adjuvants Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Route Of Administration
- 7.4.7.3. Market Size and Forecast, By Type Of Animal
- 7.4.8. Australia Veterinary Vaccine Adjuvants Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Route Of Administration
- 7.4.8.3. Market Size and Forecast, By Type Of Animal
- 7.4.9. India Veterinary Vaccine Adjuvants Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Route Of Administration
- 7.4.9.3. Market Size and Forecast, By Type Of Animal
- 7.4.10. South Korea Veterinary Vaccine Adjuvants Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Route Of Administration
- 7.4.10.3. Market Size and Forecast, By Type Of Animal
- 7.4.11. Rest of Asia-Pacific Veterinary Vaccine Adjuvants Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Route Of Administration
- 7.4.11.3. Market Size and Forecast, By Type Of Animal
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Route Of Administration
- 7.5.4. Market Size and Forecast, By Type Of Animal
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Veterinary Vaccine Adjuvants Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Route Of Administration
- 7.5.6.3. Market Size and Forecast, By Type Of Animal
- 7.5.7. Saudi Arabia Veterinary Vaccine Adjuvants Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Route Of Administration
- 7.5.7.3. Market Size and Forecast, By Type Of Animal
- 7.5.8. South Africa Veterinary Vaccine Adjuvants Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Route Of Administration
- 7.5.8.3. Market Size and Forecast, By Type Of Animal
- 7.5.9. Rest of LAMEA Veterinary Vaccine Adjuvants Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Route Of Administration
- 7.5.9.3. Market Size and Forecast, By Type Of Animal
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. SEPPIC
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. SPI Pharma, Inc.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Bioveta AS
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Croda Internation PLC
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Merck And Co., Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. MVP Laboratories
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. OZ Biosciences
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. InvivoGen Corporation.
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Evonik Industries AG
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Zoetis, Inc.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. VETERINARY VACCINE ADJUVANTS MARKET FOR ALUM AND CALCIUM SALTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. VETERINARY VACCINE ADJUVANTS MARKET FOR OIL EMULSION ADJUVANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. VETERINARY VACCINE ADJUVANTS MARKET FOR LIPOSOMES AND ARCHAEOSOMES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. VETERINARY VACCINE ADJUVANTS MARKET FOR NANOPARTICLES AND MICROPARTICLES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. VETERINARY VACCINE ADJUVANTS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 8. VETERINARY VACCINE ADJUVANTS MARKET FOR ORAL, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. VETERINARY VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. VETERINARY VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. VETERINARY VACCINE ADJUVANTS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 13. VETERINARY VACCINE ADJUVANTS MARKET FOR LIVESTOCK ANIMALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. VETERINARY VACCINE ADJUVANTS MARKET FOR COMPANION ANIMALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. VETERINARY VACCINE ADJUVANTS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 22. U.S. VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 25. CANADA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 28. MEXICO VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 33. GERMANY VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 34. GERMANY VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 36. FRANCE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 37. FRANCE VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 38. FRANCE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 39. UK VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. UK VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 41. UK VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 42. ITALY VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 43. ITALY VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 44. ITALY VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 45. SPAIN VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 46. SPAIN VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 47. SPAIN VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF EUROPE VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 55. JAPAN VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 56. JAPAN VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 58. CHINA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 59. CHINA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 60. CHINA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 61. AUSTRALIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 62. AUSTRALIA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 63. AUSTRALIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 64. INDIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 65. INDIA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 66. INDIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 67. SOUTH KOREA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 68. SOUTH KOREA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 69. SOUTH KOREA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 72. REST OF ASIA-PACIFIC VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 79. BRAZIL VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 80. SAUDI ARABIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 81. SAUDI ARABIA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 83. SOUTH AFRICA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 84. SOUTH AFRICA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 85. SOUTH AFRICA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA VETERINARY VACCINE ADJUVANTS MARKET, BY TYPE OF ANIMAL, 2024 - 2033 ($BILLION)
- TABLE 89. SEPPIC: KEY EXECUTIVES
- TABLE 90. SEPPIC: COMPANY SNAPSHOT
- TABLE 91. SEPPIC: OPERATING SEGMENTS
- TABLE 92. SEPPIC: PRODUCT PORTFOLIO
- TABLE 93. SEPPIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 94. SPI PHARMA, INC.: KEY EXECUTIVES
- TABLE 95. SPI PHARMA, INC.: COMPANY SNAPSHOT
- TABLE 96. SPI PHARMA, INC.: OPERATING SEGMENTS
- TABLE 97. SPI PHARMA, INC.: PRODUCT PORTFOLIO
- TABLE 98. SPI PHARMA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 99. BIOVETA AS: KEY EXECUTIVES
- TABLE 100. BIOVETA AS: COMPANY SNAPSHOT
- TABLE 101. BIOVETA AS: OPERATING SEGMENTS
- TABLE 102. BIOVETA AS: PRODUCT PORTFOLIO
- TABLE 103. BIOVETA AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 104. CRODA INTERNATION PLC: KEY EXECUTIVES
- TABLE 105. CRODA INTERNATION PLC: COMPANY SNAPSHOT
- TABLE 106. CRODA INTERNATION PLC: OPERATING SEGMENTS
- TABLE 107. CRODA INTERNATION PLC: PRODUCT PORTFOLIO
- TABLE 108. CRODA INTERNATION PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 109. MERCK AND CO., INC.: KEY EXECUTIVES
- TABLE 110. MERCK AND CO., INC.: COMPANY SNAPSHOT
- TABLE 111. MERCK AND CO., INC.: OPERATING SEGMENTS
- TABLE 112. MERCK AND CO., INC.: PRODUCT PORTFOLIO
- TABLE 113. MERCK AND CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 114. MVP LABORATORIES: KEY EXECUTIVES
- TABLE 115. MVP LABORATORIES: COMPANY SNAPSHOT
- TABLE 116. MVP LABORATORIES: OPERATING SEGMENTS
- TABLE 117. MVP LABORATORIES: PRODUCT PORTFOLIO
- TABLE 118. MVP LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119. OZ BIOSCIENCES: KEY EXECUTIVES
- TABLE 120. OZ BIOSCIENCES: COMPANY SNAPSHOT
- TABLE 121. OZ BIOSCIENCES: OPERATING SEGMENTS
- TABLE 122. OZ BIOSCIENCES: PRODUCT PORTFOLIO
- TABLE 123. OZ BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 124. INVIVOGEN CORPORATION.: KEY EXECUTIVES
- TABLE 125. INVIVOGEN CORPORATION.: COMPANY SNAPSHOT
- TABLE 126. INVIVOGEN CORPORATION.: OPERATING SEGMENTS
- TABLE 127. INVIVOGEN CORPORATION.: PRODUCT PORTFOLIO
- TABLE 128. INVIVOGEN CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129. EVONIK INDUSTRIES AG: KEY EXECUTIVES
- TABLE 130. EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
- TABLE 131. EVONIK INDUSTRIES AG: OPERATING SEGMENTS
- TABLE 132. EVONIK INDUSTRIES AG: PRODUCT PORTFOLIO
- TABLE 133. EVONIK INDUSTRIES AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134. ZOETIS, INC.: KEY EXECUTIVES
- TABLE 135. ZOETIS, INC.: COMPANY SNAPSHOT
- TABLE 136. ZOETIS, INC.: OPERATING SEGMENTS
- TABLE 137. ZOETIS, INC.: PRODUCT PORTFOLIO
- TABLE 138. ZOETIS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF VETERINARY VACCINE ADJUVANTS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN VETERINARY VACCINE ADJUVANTS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVETERINARY VACCINE ADJUVANTS MARKET
- FIGURE 10. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET SEGMENTATION, BY TYPE
- FIGURE 11. VETERINARY VACCINE ADJUVANTS MARKET FOR ALUM AND CALCIUM SALTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. VETERINARY VACCINE ADJUVANTS MARKET FOR OIL EMULSION ADJUVANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. VETERINARY VACCINE ADJUVANTS MARKET FOR LIPOSOMES AND ARCHAEOSOMES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. VETERINARY VACCINE ADJUVANTS MARKET FOR NANOPARTICLES AND MICROPARTICLES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. VETERINARY VACCINE ADJUVANTS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET SEGMENTATION, BY ROUTE OF ADMINISTRATION
- FIGURE 17. VETERINARY VACCINE ADJUVANTS MARKET FOR ORAL, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. VETERINARY VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. VETERINARY VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. VETERINARY VACCINE ADJUVANTS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. GLOBAL VETERINARY VACCINE ADJUVANTS MARKET SEGMENTATION, BY TYPE OF ANIMAL
- FIGURE 22. VETERINARY VACCINE ADJUVANTS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. VETERINARY VACCINE ADJUVANTS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 28. COMPETITIVE DASHBOARD
- FIGURE 29. COMPETITIVE HEATMAP: VETERINARY VACCINE ADJUVANTS MARKET
- FIGURE 30. TOP PLAYER POSITIONING, 2023
- FIGURE 31. SEPPIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. SEPPIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. SEPPIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. SPI PHARMA, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. SPI PHARMA, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. SPI PHARMA, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. BIOVETA AS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. BIOVETA AS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. BIOVETA AS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. CRODA INTERNATION PLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. CRODA INTERNATION PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. CRODA INTERNATION PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. MERCK AND CO., INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. MERCK AND CO., INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. MERCK AND CO., INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. MVP LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. MVP LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. MVP LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. OZ BIOSCIENCES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. OZ BIOSCIENCES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. OZ BIOSCIENCES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. INVIVOGEN CORPORATION.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. INVIVOGEN CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. INVIVOGEN CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. EVONIK INDUSTRIES AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. EVONIK INDUSTRIES AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. EVONIK INDUSTRIES AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. ZOETIS, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. ZOETIS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. ZOETIS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook